Ditchcarbon
  • Customers
  1. Organizations
  2. SmithKline Beecham Limited
Public Profile
Research Pending

This profile hasn't yet passed our validation checks

Submit your email to push it up the queue

We'll prioritize this organization's research and notify you when detailed sustainability data becomes available.

Pharmaceutical Preparation Manufacturing
GB
updated 7 months ago

SmithKline Beecham Limited

Company website

SmithKline Beecham Limited, commonly referred to as SB or GlaxoSmithKline (GSK), is a prominent player in the global pharmaceutical and healthcare industry. Headquartered in Great Britain, the company has a significant operational presence across Europe, North America, and Asia. Founded in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham, GSK has since achieved numerous milestones, including advancements in vaccine development and consumer healthcare products. GSK's core offerings encompass prescription medicines, vaccines, and consumer health products, distinguished by their commitment to innovation and quality. The company is renowned for its research-driven approach, particularly in areas such as respiratory health, HIV, and oncology. With a strong market position, GSK consistently ranks among the top pharmaceutical companies globally, recognised for its contributions to public health and commitment to sustainability.

DitchCarbon Score

How does SmithKline Beecham Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

100

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

29

Industry Benchmark

SmithKline Beecham Limited's score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

100%

Let us know if this data was useful to you

SmithKline Beecham Limited's reported carbon emissions

Inherited from GSK plc

SmithKline Beecham Limited, headquartered in Great Britain, currently does not report specific carbon emissions data, as no emissions figures are available. The company is a current subsidiary of GSK plc, which cascades its climate commitments and initiatives down to SmithKline Beecham Limited. GSK plc has set ambitious climate targets, including commitments to reduce greenhouse gas emissions across its operations. These initiatives are part of a broader strategy to achieve net-zero emissions by 2030 for Scope 1 and 2 emissions, and by 2045 for Scope 3 emissions. The specific reduction targets and achievements of GSK plc are inherited by SmithKline Beecham Limited, reflecting the company's commitment to sustainability and climate action. As a subsidiary, SmithKline Beecham Limited aligns with GSK plc's participation in various climate initiatives, including the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and the RE100 initiative, which focuses on sourcing 100% renewable electricity. These commitments underscore the company's dedication to addressing climate change and reducing its carbon footprint in line with industry standards.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20142015201620172018201920202021202220232024
Scope 1
851,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 2
745,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
00,000,000
00,000,000
00,000,000
Scope 3
16,093,000,000
00,000,000,000
00,000,000,000
00,000,000,000
00,000,000,000
-
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. SmithKline Beecham Limited's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for SmithKline Beecham Limited is in GB, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

SmithKline Beecham Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250917.4
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy